Kemin Pharma Developing Two New Molecules That Appear Promising in the Battle Against Hepatitis C
Monday January 12, 4:53 pm ET
HERENTALS, Belgium, Jan. 12 /PRNewswire/ -- Kemin Pharma has identified two different molecules that appear to have very good biological effects against the hepatitis C virus (HCV). The first of these molecules is already being tested in Phase II clinical trials. Kemin Pharma discovered molecule KPE02003002, a synthetic derivative of a phytochemical with several chiral centers, in October 2002, through a collaborative effort with the National Institutes of Health in Bethesda, Maryland, and the Rega Institute for Medical Research in Leuven, Belgium. The second molecule, KPE00001113, was discovered in 2003 as part of the same collaborative, in vitro, antiviral screening program.
[Non-text portions of this message have been removed]